In 2025, the MEA industry amounted to USD 9.17 billion, showing a year-on-year increase of 1.3%.
The MEA Infusion Services Market will reach USD 25.95 billion by 2033, achieving an expected CAGR of 13.9% over the forecast timeline.
Government-led oncology center investments in Gulf states and select African economies are steadily increasing biologic infusion infrastructure density.
World Health Organization regional cancer data show rising non-communicable disease prevalence across the Middle East and Africa, underpinning long-term systemic therapy expansion.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]